InvestorsHub Logo
Followers 31
Posts 2649
Boards Moderated 0
Alias Born 10/28/2013

Re: kabunushi post# 49604

Tuesday, 01/05/2016 9:56:12 AM

Tuesday, January 05, 2016 9:56:12 AM

Post# of 702431
Re: Philip Powers' Obituary: Looks like LP had a sister that died of Leukemia in 1962. Her dad fought cancer multiple times.

As I vaguely recall, she also lost a stepson or step-daughter to cancer.

Of course Afford is right that none of that assures her altruism in dealing with NWBO...

My concern would be that even if she is pure as fresh snow, she has to live to fight another day against cancer, and Cognate appears to be the higher priority. From day 1, Cognate was less risky because it can work for multiple companies with multiple therapies.

If the future is autologous immunotherapy, then the threat to that future is the high cost of such therapy. The threat of companies failing on their own like Dendreon, but also the threat of people trying to stop such startups from making it, due to the financial threat to... insurance companies, governments, etc. By building and scaling Cognate she may be bringing the cost of autologous immunotherapy down to affordable levels, for anyone buying Cognate's services. That may be her priority, and that may be the only logical path.

None of that means that NWBO is not going to make it, it just suggests that if push comes to shove, Cognate lives.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News